Sopharma AD (BB) (BGSFA)

Currency in EUR
2.400
+0.050(+2.13%)
Closed·
Advertisement
BGSFA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.3502.410
52 wk Range
1.4102.900
Key Statistics
Bid/Ask
3.94 / 3.99
Prev. Close
5.8
Open
2.35
Day's Range
2.35-2.41
52 wk Range
1.41-2.9
Volume
68.63K
Average Volume (3m)
157.07K
1-Year Change
-12.4088%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BGSFA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Earnings

Latest Release
28/08/2026
EPS / Forecast
0.03 / --
Revenue / Forecast
374.54M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.23%
Dividend Yield
1.67%
Industry Median 3.15%
Annualised payout
0.10
Paid annually
5-Years Growth
+25.67%
Growth Streak

Compare BGSFA to Peers and Sector

Metrics to compare
BGSFA
Peers
Sector
Relationship
P/E Ratio
15.2x22.2x−0.4x
PEG Ratio
0.120.000.00
Price/Book
2.4x4.0x2.6x
Price / LTM Sales
0.9x3.2x3.0x
Upside (Analyst Target)
-12.4%49.0%
Fair Value Upside
Unlock12.6%6.5%Unlock

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana, a herbal medicine to reduce the stress; veterinary vaccines; and medical devices, such as gauzes, compresses, and dressing. The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; and yophilic products, ointments, syrups, drops, suppositories, inhalers, haemodialysis concentrates, sachets, substances, infusion solutions, veterinary vaccines, solutions and chemical substances and mixture. In addition, the company distributes pharmaceuticals, and sanitary and hygiene products; and provides contract manufacturing services, regulatory services, laboratory analysis, transport services, and other services. Further, it is involved in trading of pharmaceuticals; manufacturing medical plant; and provision of public opinion research services. Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and rental of properties, as well as in trading, consulting, and other activities. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.53M0.28%3.66M
Other Institutional Investors
307.16M57.05%737.18M
Public Companies & Retail Investors
229.72M42.67%551.33M
Total
538.41M100.00%1.29B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Donev investments holding AD40.31%217,010,935520,826
Telekomplekt Invest AD16.74%90,147,151216,353

People Also Watch

2.670
BREF
0.00%
7.0800
DUH
+0.28%
7.480
BGBSE
-1.06%
0.97
GR6
-1.02%

FAQ

What Is the Sopharma AD (Sofia: BGSFA) Share Price Today?

The Sopharma AD stock price today is 2.400 EUR.

What Stock Exchange Does Sopharma AD (BGSFA) Trade On?

Sopharma AD is listed and trades on the Sofia Stock Exchange.

What Is the Ticker (Stock Symbol) for Sopharma AD?

The stock symbol (also called a 'ticker') for Sopharma AD is "BGSFA."

Does Sopharma AD Pay Dividends? What’s The Current BGSFA Dividend Yield?

Yes, BGSFA Pays Dividends to its Shareholders. The current Sopharma AD dividend yield is 1.67%.

What Is the Current Sopharma AD Market Capitalisation?

As of today, Sopharma AD (Sofia: BGSFA) market cap is 1.290B EUR.

What Is Sopharma AD's (BGSFA) Earnings Per Share (TTM)?

The Sopharma AD EPS is currently 0.228 (Trailing Twelve Months).

When Is the Next Sopharma AD Earnings Date?

Sopharma AD's next earnings report will be released on 04/03/2026.

Is BGSFA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Sopharma AD moving averages and other technical indicators, the daily buy/sell signal for BGSFA stock is Strong Buy.

How Many Times Has Sopharma AD Stock Split?

Sopharma AD has split 2 times. (See the BGSFA stock split history page for full effective split date and price information.)

How Many Employees Does Sopharma AD Have?

Sopharma AD has 6049 employees, based on their latest Companies House report.

What is the current trading status of Sopharma AD (Sofia: BGSFA)?

As of 08/09/2026, Sopharma AD (BGSFA) is trading at a share price of 2.400 EUR, with a previous close of 5.800 EUR. The stock has fluctuated within a day range of 2.350 EUR to 2.410 EUR, while its 52-week range spans from 1.410 EUR to 2.900 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.